US 10927161
Methods for modulating an immune response
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 10927161 (Methods for modulating an immune response) held by Cue Biopharma, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K38/2013, A61K39/3955